Pregled bibliografske jedinice broj: 1263286
Impact of COVID-19 on vascular patients worldwide: analysis of the COVIDSurg data
Impact of COVID-19 on vascular patients worldwide: analysis of the COVIDSurg data // Journal of cardiovascular surgery, 62 (2021), 6; 558-570 doi:10.23736/S0021-9509.21.12024-5 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1263286 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Impact of COVID-19 on vascular patients worldwide:
analysis of the COVIDSurg data
Autori
Hitchman, Louise ; Machin, Matthew
Kolaboracija
The COVIDSurg Collaborative and Vascular and Endovascular Research Network
Izvornik
Journal of cardiovascular surgery (0021-9509) 62
(2021), 6;
558-570
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
COVID-19 ; vascular surgical procedures ; health care outcome assessment
Sažetak
BACKGROUND: The COVIDSurg collaborative was an international multicenter prospective analysis of perioperative data from 235 hospitals in 24 countries. It found that perioperative COVID-19 infection was associated with a mortality rate of 24%. At the same time, the COVER study demonstrated similarly high perioperative mortality rates in vascular surgical patients undergoing vascular interventions even without COVID-19, likely associated with the high burden of comorbidity associated with vascular patients. This is a vascular subgroup analysis of the COVIDSurg cohort. METHODS: All patients with a suspected or confirmed diagnosis of COVID-19 in the 7 days prior to, or in the 30 days following a vascular procedure were included. The primary outcome was 30-day mortality. Secondary outcomes were pulmonary complications (adult respiratory distress syndrome, pulmonary embolism, pneumonia and respiratory failure). Logistic regression was undertaken for dichotomous outcomes. RESULTS: Overall, 602 patients were included in this subgroup analysis, of which 88.4% were emergencies. The most common operations performed were for vascular-related dialysis access procedures (20.1%, N.=121). The combined 30-day mortality rate was 27.2%. Composite secondary pulmonary outcomes occurred in half of the vascular patients (N.=275, 45.7%). CONCLUSIONS: Mortality following vascular surgery in COVID positive patients was significantly higher than levels reported pre- pandemic, and similar to that seen in other specialties in the COVIDSurg cohort. Initiatives and surgical pathways that ensure vascular patients are protected from exposure to COVID-19 in the peri-operative period are vital to protect against excess mortality.
Izvorni jezik
Hrvatski
Znanstvena područja
Kliničke medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
Napomena
The COVIDSurg Collaborative and Vascular and
Endovascular Research Network:
Kopjar, Tomislav
Mihanović, Jakov
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
Sveučilište u Zadru,
Opća bolnica Zadar
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE